Shared Responsibility Between General Practitioners and Highly Specialized Hospitals in Spinal Cord Injury
NCT ID: NCT04071938
Last Updated: 2021-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
273 participants
INTERVENTIONAL
2019-02-01
2022-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the German Short-Form Qualiveen Questionnaire
NCT03898258
Sweat Gland Function in Patients With Failed Back Surgery Syndrome, Treated With Spinal Cord Stimulation
NCT04668482
Fatigue Induced by Overground Wheelchair Propulsion in Persons With a Spinal Cord Injury: Upper Limb Saving or Straining?
NCT03153033
Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury
NCT03707704
Shoulder Health After Rehabilitation and Performance Training
NCT07245706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study interventions are educational modules on bladder, bowel, skin-care, and pain management which will be provided to participating GPs by Spinal Cord Injury specialists. In addition visits by specialized nurses to the participating GPs at their practices to support the establishment of specialized care on-site.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Physicians: 10 GPs from 10 practices who treat patient with Spinal cord injury (SCI) and 10 SCI specialists.
Patients: 270 people with SCI within 25 minutes vehicle driving distance to the GP practices will be in the intervention group
Teaching to GPs
Educational modules on bladder, bowel and skin-care, and pain management will be provided to participating GPs by Spinal Cord Injury specialists
Site visits to GP practices
Visits by specialized nurses to the participating GPs at their practices to support the establishment of specialized care on-site
Control group
Physicians: 20 GPs who treat patient with SCI will not receive any intervention. They will be completing the questionnaire (DOC) and assessed for satisfaction with collaboration with the SCI specialist.
Patients: 210 people with spinal cord injury outside the catchment area of the intervention group will be receiving usual care (no intervention)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teaching to GPs
Educational modules on bladder, bowel and skin-care, and pain management will be provided to participating GPs by Spinal Cord Injury specialists
Site visits to GP practices
Visits by specialized nurses to the participating GPs at their practices to support the establishment of specialized care on-site
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GPs practicing in medium to large group practice
* The practice is wheelchair accessible and remote to SCI specialized centers
* Proficiency certificate in ultrasonography
Patients:
* Diagnosed with traumatic or non-traumatic, sensory or motor complete or incomplete, chronic SCI
* 18 years or older
* Permanently reside in Switzerland
* Reside farther than 25 minutes driving distance from a specialized SCI center
* Understand German, English, Italian
* Informed consent
* Additionally in treatment group: Patients with chronic SCI Living in the region of a participating GP irrespective if they visit the participating primary care practice.
* Additionally in control group: individuals with SCI who live outside the catchment areas
Exclusion Criteria
\- Acute SCI or during first rehabilitation phase - Congenital conditions leading to paraplegia or tetraplegia, including spina bifida - Neurodegenerative disorders such as multiple sclerosis and amyotrophic lateral sclerosis - Guillain-Barré syndrome
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schweizer Paraplegiker Forschung
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Armin Gemperli, PhD
Role: PRINCIPAL_INVESTIGATOR
Schweizer Paraplegiker Forschung
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schweizer Paraplegiker Forschung
Nottwil, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tomaschek R, Touhami D, Essig S, Gemperli A. Shared responsibility between general practitioners and highly specialized physicians in chronic spinal cord injury: Study protocol for a nationwide pragmatic nonrandomized interventional study. Contemp Clin Trials Commun. 2021 Nov 17;24:100873. doi: 10.1016/j.conctc.2021.100873. eCollection 2021 Dec.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCICO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.